The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitelegg, A. M. E.
Right arrow Articles by Barber, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitelegg, A. M. E.
Right arrow Articles by Barber, L. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2005, 175: 1706-1714.
Copyright © 2005 by The American Association of Immunologists

Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers1

Alison M. E. Whitelegg*,2, Liesbeth E. M. Oosten{dagger},2, Susan Jordan*, Michel Kester{ddagger}, Astrid G. S. van Halteren{dagger}, J. Alejandro Madrigal*, Els Goulmy{dagger} and Linda D. Barber*,3

* The Anthony Nolan Research Institute, Royal Free Hospital, Hampstead, London, United Kingdom; {dagger} Department of Immunohematology and Blood Transfusion, and {ddagger} Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Alloreactive T cells are involved in injurious graft rejection and graft-vs-host disease. However, they can also evoke beneficial responses to tumor Ags restricted by foreign MHC molecules. Manipulation of these alloreactivities requires information on the basis of T cell allorecognition. The vigorous T cell response to foreign MHC molecules may arise from peptide-independent recognition of polymorphic residues of foreign MHC molecules or peptide-specific recognition of novel peptides presented by foreign MHC molecules. We investigated CD8+ T cell allorecognition using recombinant HLA class I/peptide complexes. Peptide-specific allorecognition was examined using tetramers of HLA-A*0201 representing five peptides derived from ubiquitously expressed self-proteins that are known to bind endogenously to HLA-A*0201. Distinct subsets of CD8+ T cells specific for each HLA-A*0201/peptide combination were detected within four in vitro-stimulated T cell populations specific for foreign HLA-A*0201. Peptide-independent allorecognition was investigated using artificial Ag-presenting constructs (aAPCs) coated with CD54, CD80, and functional densities of a single HLA-A*0201/peptide combination for four different peptides. None of the four T cell populations specific for foreign HLA-A*0201 were stimulated by the aAPCs, whereas they did produce IFN-{gamma} upon stimulation with cells naturally expressing HLA-A*0201. Thus, aAPCs did not stimulate putative peptide-independent allorestricted T cells. The results show that these alloreactive populations comprise subsets of T cells, each specific for a self-peptide presented by foreign class I molecules, with no evidence of peptide-independent components.




This article has been cited by other articles:


Home page
Int ImmunolHome page
L. E. M. Oosten, D. Koppers-Lalic, E. Blokland, A. Mulder, M. E. Ressing, T. Mutis, A. G. S. van Halteren, E. J. H. J. Wiertz, and E. Goulmy
TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes
Int. Immunol., September 1, 2007; 19(9): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Landais, A. Morice, H. M. Long, T. A. Haigh, B. Charreau, M. Bonneville, G. S. Taylor, and E. Houssaint
EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses
J. Immunol., August 1, 2006; 177(3): 1427 - 1433.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.